Evidence map›Paper›PMID 32474835›Full record

ReviewMolecular neurobiology2020

Molecular, Structural, Functional, and Pharmacological Sites for Vesicular Glutamate Transporter Regulation.

Nicolas Pietrancosta, Mahamadou Djibo, Stephanie Daumas, Salah El Mestikawy, Jeffrey D Erickson

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Open veterinary journal · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Neurochemistry of the mammillary body.Brain structure & function · 2023
    Review
  19. Article
  20. Vesicular glutamate transporters are HNature communications · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Nicolas PietrancostaNeuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS) INSERM, CNRS, Sorbonne Université, Paris, France. nicolas.pietrancosta@sorbonne-universite.fr.
Mahamadou DjiboSorbonne Paris Cité, Université Paris Descartes, LCBPT, UMR 8601, 75006, Paris, France.
Stephanie DaumasNeuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS) INSERM, CNRS, Sorbonne Université, Paris, France.
Salah El MestikawyNeuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS) INSERM, CNRS, Sorbonne Université, Paris, France. salah.el_mestikawy@upmc.fr.
Jeffrey D EricksonNeuroscience Center, Louisiana State University, New Orleans, LA, 70112, USA. jerick@lsuhsc.edu.ORCID https://orcid.org/0000-0003-4598-9898
Centre National de la Recherche Scientifique · FRDélégation Paris 5 · FRLouisiana State University · US

Funding

Novel presynaptic agents to prevent glutamate-induced neural injuryR01NS113955 · NINDS · LSU HEALTH SCIENCES CENTER · PI ERICKSON, JEFFREY D · 2020 to 2024
$1.6M
Neuronal Activity-Regulated Glutamine Transporter R21NS109668 · NINDS · LSU HEALTH SCIENCES CENTER · PI ERICKSON, JEFFREY D · 2019 to 2020
$423k
Campus France (FR) ANR-13-SAMA-0005-01Fonds de Recherche du Québec - Santé FRQS 30582National Sciences and Engineering Research Council RGPIN/04682-2017Natural Sciences and Engineering Research Council RGPIN/386431-2012NINDS NIH HHS NS109668NINDS NIH HHS NS113955-01NINDS NIH HHS R01 NS113955NINDS NIH HHS R21 NS109668
6 · The paper itself

Abstract

Vesicular glutamate transporters (VGLUTs) control quantal size of glutamatergic transmission and have been the center of numerous studies over the past two decades. VGLUTs contain two independent transport modes that facilitate glutamate packaging into synaptic vesicles and phosphate (Pi) ion transport into the synaptic terminal. While a transmembrane proton electrical gradient established by a vacuolar-type ATPase powers vesicular glutamate transport, recent studies indicate that binding sites and flux properties for chloride, potassium, and protons within VGLUTs themselves regulate VGLUT activity as well. These intrinsic ionic binding and flux properties of VGLUTs can therefore be modulated by neurophysiological conditions to affect levels of glutamate available for release from synapses. Despite their extraordinary importance, specific and high-affinity pharmacological compounds that interact with these sites and regulate VGLUT function, distinguish between the various modes of transport, and the different isoforms themselves, are lacking. In this review, we provide an overview of the physiologic sites for VGLUT regulation that could modulate glutamate release in an over-active synapse or in a disease state.

Indexed as

AnimalsGene Expression RegulationGlutamic AcidHumansNeuronsSynapsesSynaptic TransmissionSynaptic VesiclesVesicular Glutamate Transport ProteinsGlutamic AcidVesicular Glutamate Transport ProteinsATPaseGlutamate (Glu)Vesicular glutamate transporters (VGLUTs)

Identifiers

PMID32474835
PMCPMC7261050
OpenAlexW3030196302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.